These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 3089007

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
    Saavedra S, Vera D, Ramírez-Ronda CH.
    Am J Med; 1986 Jun 30; 80(6B):65-70. PubMed ID: 3014877
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An evaluation of the susceptibility patterns of gram-negative organisms isolated in cancer centres with aminoglycoside usage.
    Muscato JJ, Wilbur DW, Stout JJ, Fahrlender RA.
    J Antimicrob Chemother; 1991 May 30; 27 Suppl C():1-7. PubMed ID: 1906860
    [Abstract] [Full Text] [Related]

  • 7. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L, Robinson RG, Koornhof HJ.
    S Afr Med J; 1984 Jun 09; 65(23):922-4. PubMed ID: 6427946
    [Abstract] [Full Text] [Related]

  • 8. New epidemiological data on resistance to netilmicin and other aminoglycosides.
    Toscano MA, Minneci M, Salmeri M, Nicoletti G.
    J Chemother; 1991 Dec 09; 3(6):352-6. PubMed ID: 1819617
    [Abstract] [Full Text] [Related]

  • 9. Aminoglycoside resistance patterns in Turkey.
    Akalin HE, Torun M, Alacam R.
    Scand J Infect Dis; 1988 Dec 09; 20(2):199-203. PubMed ID: 2840733
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Resistance of gram-negative bacilli and staphylococci from blood cultures to aminoglycoside antibiotics. Comparison of 3 in vitro investigations from Austria 1982-1988.
    Mittermayer H, Rotter M, Breitfellner G, Riezinger F, Thiel W, Binder L, Watschinger R.
    Zentralbl Bakteriol; 1990 Apr 09; 272(4):448-57. PubMed ID: 2113808
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of the AutoMicrobic system for susceptibility testing of aminoglycosides and gram-negative bacilli.
    Hindler JA, Bruckner DA.
    J Clin Microbiol; 1987 Mar 09; 25(3):546-50. PubMed ID: 3571458
    [Abstract] [Full Text] [Related]

  • 16. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C, Kauffman CA.
    Infection; 1978 Mar 09; 6(3):111-5. PubMed ID: 98451
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
    DiPersio JR, Krafczyk TL.
    Chemotherapy; 1980 Mar 09; 26(5):323-33. PubMed ID: 7389428
    [Abstract] [Full Text] [Related]

  • 18. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H.
    Am J Med; 1986 Jun 30; 80(6B):126-37. PubMed ID: 3088998
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.
    Marks MI, Hammerberg S, Greenstone G, Silver B.
    Antimicrob Agents Chemother; 1976 Sep 30; 10(3):399-401. PubMed ID: 825026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.